Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 2 | Mind Blowing Facts

Read How Analysts Reacted To Blend Labs' Q4 Results

Analysts mainly slashed the price targets or downgraded the rating on Blend Labs Inc (NYSE:BLND) post Q4 results. KeyBanc analyst Josh Beck lowered the price target to $6 from $10 (26% upside) and kept an Overweight. The company's FY22 revenue forecast was well below the Street's $343.8 million, reflecting the negative impact of higher rates…

CrowdStrike Shares Soar Premarket As Analysts Paint Huge Upsides Post Q4

CrowdStrike Shares Soar Premarket As Analysts Paint Huge Upsides Post Q4

Analysts painted a sharp upside to CrowdStrike Holdings Inc (NASDAQ:CRWD) after it reported a stronger than expected Q4 and initial FY23 growth outlook. ARR rose 65% Y/Y and grew to $1.73 billion, of which $216.9 million was net new ARR added in Q4. BTIG analyst Gray Powell upgraded to Buy from Neutral with a $257 PT (51.4%…

3 Reasons Why This Natera Analyst Says The Selloff Is Overdone

3 Reasons Why This Natera Analyst Says The Selloff Is Overdone

Natera Inc (NASDAQ: NTRA) analyst Kyle Mikson of Canaccord Genuity Capital reiterated a Buy rating Wednesday on the genetic testing company following a Hindenburg Research short

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Analysts Move To Sidelines On Vicarious Surgical After Regulatory Update

Piper Sandler has downgraded Vicarious Surgical Inc (NASDAQ:RBOT) to Neutral from Overweight with a price target of $7, down from $16, below expected Q4 results. A majority of the earnings call focused on the Company's regulatory update. Vicarious announced its plans to pursue a De Novo FDA pathway, including a pre-market study, for its…

Analysts Continue To See Sharp Upside In Sprout Social Post Q4 Results

Analysts cut their price targets on Sprout Social Inc (NASDAQ:SPT) post Q4 results. Needham analyst Scott Berg lowered the price target to $75 from $160 (37% upside) given the significant multiple compression across high growth software but kept a Buy. The company's Q4 results were "impressive," highlighted by the acceleration of upmarket demand, record large…

Read How Analysts Reacted To Generac's Q4 Results

Analysts updated the price target for Generac Holdings Inc. (NYSE:GNRC) post Q4 results. Canaccord analyst Jed Dorsheimer lowered the price target to $556 from $575 and maintained a Buy rating on the shares. The analyst believes margin pressures from the supply chain, logistics, and inflation will peak in 1Q22 and subsequently succumb to the power…

Twilio Shares Pop As Analysts Continue To See Sharp Upside Post Q4

Analysts mostly raised their price targets on Twilio Inc (NYSE:TWLO) post Q4 beat and continue to see sharp upside to the stock. Macquarie maintained Twilio with an Outperform and raised the price target from $281 to $306 (51.5% upside). KeyBanc analyst Steve Enders raised the firm's price target on Twilio to $320 from $283 (58.4% upside) and kept…

inkl

Read news from The Economist, FT, and more,
with one subscription

1 2

People

Jeffrey Hammond

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

380,505 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play